A Lifestyle Intervention Targeting Enhanced Health and Function for Persons With Chronic SCI in Caregiver/Care-Receiver Relationships: Effects of Caregiver Co-Treatment
A Lifestyle Intervention Targeting Enhanced Health and Function for Persons With Chronic SCI in Caregiver/Care-Receiver Relationships: Effects of Caregiver Co-Treatment
This study determines in people with chronic SCI the health and functional impact and user
 acceptance and satisfaction - of a 6-month comprehensive Lifestyle Intervention; the impact
 and user acceptance/satisfaction of a Complementary Caregiver Curriculum (CCC) on SCI
 caregiver health and function and whether the complementary caregiver curriculum (CCC)
 enhances health and functional benefits obtained by the SCI dyadic partner enrolled in the LI
 program.
The current proposal addresses the compelling problem of cardiometabolic disease risk and
 functional decline in persons with disability from spinal cord injuries and disease (SCI/D).
 'Obesity/overweight' addressed in this project - a major component of cardiometabolic disease
 risk (CMD) - represents the sole chronic condition whose speed of growth and widespread
 dispersion parallels pandemics of communicable diseases. Nearly 2/3 of Americans are
 currently overweight or obese, with a growth rate exceeding 10% in the past decade. The
 prevalence and impact of obesity is expected to worsen. Obesity-related health risks cross
 all lines of gender, geographic region, socioeconomic status, race, heritage, and educational
 level, and are strongly associated with comorbid conditions including: cardiometabolic
 syndrome, hypertension, diabetes, inflammatory disease, coronary artery disease, congestive
 heart failure, stroke, osteoarthritis, sleep apnea, depression, cancer, respiratory failure,
 disorders of coagulation, and degenerative joint disease. All of these disorders are widely
 reported at elevated prevalence in people with physical disability (PWPD). A study based on
 pooled data from the 1994-5 National Health Interview Survey, the 1994-5 Disability
 Supplement, and the 1995 'Healthy People 2000' Supplement reported a 66% higher rate of
 obesity among PWPD than the general population. A regional study reported that extreme
 obesity (body mass index [BMI] ≥ 40) was four times more prevalent among PWPD than those
 without. Prevalence rates for overweight and obesity in persons with chronic SCI/D are
 equally daunting, and range from 55% to 95.7% of the population. Numerous causes explain
 accretion of body fat after SCI including sarcopenia leading to loss of metabolically active
 muscle mass, reduced whole body energy expenditure, restricted choices for exercise
 conditioning, and a hypercaloric diet. Irrespective of cause, weight gain after disability
 brings about diminished work capacity, musculoskeletal decline, pain, accelerated
 cardiovascular diseases (CVD), and progressive life dissatisfaction. Overweight/obesity after
 SCI/D is also disturbingly co-morbid with dyslipidemia, glucose intolerance, and insulin
 resistance, a 'pro-inflammatory phenotype, and risks of postprandial lipemia. Increasing body
 mass (BM) promotes wheelchair injury and dysfunction, imposes significant burdens on
 self-image and perceived health, and is far more difficult to reverse than obesity occurring
 in persons without disability. Overweight in particular: a) Poses functional limitations, and
 restricts physical activity, independence, and community integration; b) affects ease of
 transferring, joint function, and fracture risk; and, c) compromises 'activities of daily
 living' (ADLs) in 39% of individuals with SCI. Despite all of these risks and concerns an
 effective solution to this problem has evaded researchers, clinicians, and stakeholders with
 SCI.

 While an overweight body has implications for health and function of PWPD, it also has an
 impact on their caregivers. Within the past quarter decade there has been a predictable shift
 of many health and function related responsibilities to adjuvant providers (i.e., healthcare
 provider extenders) -- so-called 'caregivers' - who are challenged to administer greater
 health and functional demands of aging PWPD while they are similarly experiencing health and
 functional 3 decline accompanying their own aging. This shifting of providers will likely
 continue, or possibly worsen due to an uncertain future of disability coverage within a
 tentative American health system. The investigators have already started to observe - yet not
 fully comprehend - the many complex difficulties imposed by aging on PWPD and their
 caregivers, and speculate how to effectively intervene on them. Unlike caregivers for persons
 with Alzheimer's disease and Parkinson's disease, caregivers of people with wheelchair
 dependency are required to be more physically active, lift/push/roll an impaired body far
 more often, and often assume caregiving responsibilities earlier in the life of PWPD. While
 clinicians and researchers often focus on the person with disability, their caregiver can be
 left out of the care plan. It is thus not surprising that pain, anxiety, and depression among
 caregivers of PWPD is exceedingly prevalent.

 Encouraging evidence already suggests an important role for primary and secondary lifestyle
 intervention (LI) in the form of weight-lessening and fitness-promoting nutrition and
 exercise to improve health and function of people aging with disability. Comprehensive LI
 programs of exercise, nutrition, and behavioral support for people without disabilities have
 been designed and systematically tested in multi-center clinical trials, and have been found
 effective in the short term for promoting weight loss and lessening conversion rates to frank
 diabetes. The LI programs have been compared against pharmacotherapy and have actually been
 found more effective. Programmatic modifications made for community deployment of the LI
 plans, and testing of long-term follow-up have shown remarkable success in sustaining - or
 even further improving - benefits obtained during initial treatment. These research findings
 make LI programs of weight-loss promoting reconditioning exercise, nutrition, and behavioral
 support legitimate candidates for testing in PWPD, although no studies have ever done so.
 Moreover, the impact of these interventions on caregiver burden has never been examined,
 although it is reasonable to conjecture that loss of body BM and improved fitness/function of
 care-receivers would reduce global caregiver burden. Further, evidence supports lifestyle and
 health benefits to the care-receiver when a caregiver is enrolled in a linked behavioral
 intervention program, making the relationship of the dyadic partners in benefiting one
 another through coordinated intervention an intriguing intervention benefit.

 To: a) address the concerning problem of overweight/obesity after SCI, b) better understand
 its impact on health and function of persons with SCI and their caregivers, and c) intervene
 on these hazards where inaction would forecast additional decline, the investigators will
 conduct a randomized, controlled, multi-center intervention study examining persons with
 disability from SCI and their caregivers, who will together be enrolled as dyadic partners.
 Key questions will address whether: a) people with disability from SCI benefit from the LI
 plan through improved health and function, b) caregivers of people with disability from SCI
 benefit from the LI plan through their own improved health and function, c) co-participation
 of a caregiver partner in a LI curriculum provides a cross benefit for their partner, and d)
 benefits of clinical intervention are long-lasting with minimal supervision. The
 investigators will use an intervention for all participants with SCI that is modeled after
 the Diabetes Prevention Program (DPP) that incorporates population-appropriate exercise,
 nutrition, and behavioral support. Caregivers (linked with their partners) will be randomized
 to either 'behavioral support' or a 'control condition'. Clinical training will take place
 for 6 months and then be followed by a 6-month minimally supervised extension phase. Outcomes
 tested for participants with SCI will focus on domains of health and function reflected by
 fitness, cardioendocrine risk and inflammatory stress; multi-dimensional function and pain;
 Sol and independence; and self-efficacy, program acceptance, and life satisfaction. Outcomes
 tested for caregivers will focus on multidimensional function and pain; and, Quality of Life
 (QoL) and independence, the latter including perceived caregiver burden.
Inclusion Criteria:

 a. Inclusion Criteria:

 1. Men and Women with SCI/D > 1 year, aged 18-70 years.

 2. American Spinal Injury Association (AIS) Impairment scale A-D Spinal Cord Levels C5-L1

 3. Any one or more of the following:

 1. Waist circumference >94 cm (37 inches)

 2. BMI ≥ 21 kg/m2

 3. Fasting dyslipidemia (either; High-density lipoprotein cholesterol (HDL-C)≤
 40mg/dL (men)/≤50 mg/dL (women), or Triglycerides (TG) ≥ 150 mg/dL).

 AND,

 4. Linked with caregivers: Men and women 18-70 years who consent to co-enroll in the
 study with their partner. Caregivers are defined as: Family member, significant
 others or friends living with a disabled (SCI/D) partner who provide social
 and/or physical support including personal assistance, routine emotional
 encouragement and/or social interaction.

 Exclusion Criteria:

 -  Exclusion Criteria for Participants with SCI/D:

 1. Participating in at least 30 minutes of moderate intensity physical activity on
 at least three days of the week for at least three months.

 2. Diet involving moderate caloric restriction for at least 6 months resulting in
 weight loss/gain ≥ 10% of total body mass

 3. Surgery within 3 months.

 4. Grade 3-4 pressure ulcer within 3 months;

 5. limb pain that limits exercise

 6. recurrent acute infection or illness

 7. pregnancy

 8. previous myocardial infarction (MI), or cardiac surgery

 -  Exclusion Criteria for Caregiver Participants:

 1. Participating in at least 30 minutes of moderate intensity physical activity on
 at least three days of the week for at least three months

 2. Diet involving moderate caloric restriction for at least 6 months.

 3. weight loss/gain of 10% within the preceding 6 months

 4. Surgery within 3 months.

 5. upper limb pain that limits exercise

 6. pregnancy

 7. Previous myocardial infarction (MI), cerebrovascular accident (CVA) or cardiac
 surgery that limits exercise.

 8. Type I or II diabetes by World Health Organization (WHO) criteria

 -  Other exclusions applying to groups:

 1. The following drugs: anti-hyperglycemic agents, and lipid-altering agents within
 the past 6 months. Women who become pregnant will be advised to notify study
 personnel, will be tested, and if found to be pregnant discharged from the trial.
 There is no harm caused by exercise and diet in early pregnancy. Women must wait
 6 months after child delivery to enter the study - a criterion of the Diabetes
 Prevention Program.

 2. Individuals with a diagnosis of pre-diabetes if, after 2 months of intervention
 the following diagnostic criteria of the American Diabetes Association criteria
 (ADA) are observed:

 Fasting Blood Glucose (FBG) 110-126mg/dL after a fast of 8 hours OR 2 hyperglycemia
 symptoms (i.e. Polyuria, polydipsia and unexplained weight loss) and a causal plasma
 glucose ≥200 mg/dL. In the absence of unequivocal hyperglycemia, these criteria will be
 confirmed by repeat testing per (ADA) criteria. Should repeat testing confirm diabetes,
 subjects will be discharged and referred for medical treatment.